Skip to main content
Watch Insiders
Market intelligence
TRDAHealthcare

Entrada Therapeutics Inc insider activity

In the last 90 days, 1 corporate insider purchased $29,316 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$29,316
Corporate buyers
1
Latest transaction
May 20, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
May 20, 2026Bernhardt G ZeiherCorporate insiderOpen Market Purchase5,000$5.86$29,316
May 4, 2026Natarajan SethuramanPresident, Research & Develop.Sale25,907$15.39$398,810
May 4, 2026Nathan J DowdenPresident & COOSale15,000$15.33$229,953